David J Kobulnicky, MD - Virginia Oncology Associates

Oncology Associates of Virginia, led by Dr. Elizabeth A. Harden, is a prominent healthcare provider in Newport News, VA, specializing in cancer treatment and management. With over 25 years of expertise in oncology practice management, the organization is dedicated to enhancing patient care through innovative clinical trials and a commitment to excellence in cancer treatment. As part of The US Oncology Network, the practice benefits from extensive resources, best business practices, and the support of McKesson, a trusted name in healthcare for over 180 years. This collaboration empowers local oncology practices to maintain their independence while providing cutting-edge care and improving patient outcomes. Generated from the website

Dr. Chang is board certified in Medical Oncology and Internal Medicine. Prior to joining Virginia Oncology Associates, he served as Assistant Professor for Gastrointestinal Medical Oncology at one of the nation's premiere cancer institutions, the University of Texas MD Anderson Cancer Center where he developed and directed the Immunotherapy Program for Gastrointestinal Cancers. His accomplishments in cancer research have made him a sought after thought leader in the cancer community, specifically in the areas of colorectal and pancreatic cancer, neuroendocrine tumors, as well as other gastrointestinal cancers.

Oncology Associates of Virginia, located in Newport News, VA, is a prominent provider of cancer care, leveraging over 25 years of oncology practice management expertise. As part of The US Oncology Network, they offer physicians access to essential resources, best business practices, and the support of McKesson, a trusted name in healthcare for over 180 years. Dedicated to patient-centric care, the organization emphasizes innovation and excellence in cancer treatment while empowering community practices to maintain their independence. Through participation in cutting-edge clinical trials and a commitment to enhancing oncology practices, they aim to shape the future of cancer care for patients and providers alike. Generated from the website